Treatment of postmenopausal osteoporosis with gonadal steroids.
D000367:Age Factors; D000368:Aged; D045930:Anabolic Agents / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use*; D000818:Animals; D002574:Cervical Vertebrae / Q000293:injuries; D004967:Estrogens / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D050723:Fractures, Bone / Q000150:complications; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D008593:Menopause; D008875:Middle Aged; D010006:Osteoblasts / Q000378:metabolism; D010024:Osteoporosis / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy / Q000209:etiology
D045930:Anabolic Agents; D000728:Androgens; D004967:Estrogens